SUMMARY The effects of nitroglycerin (NTG) Methods Mongrel dogs that weighed 28-38 kg were anesthetized with sodium pentobarbital, 30 mg/kg i.v. The transducers were implanted through a thoracotomy in the fifth left intercostal space. Miniature 7-MHz ultrasonic transducers (2 X 1 mm, 12 mg) were implanted on opposing surfaces of the left circumflex coronary artery 3-6 cm from its origin. The ultrasonic transducer were covered with Insl-X (Insl-X Products Corp.) and attached to a Dacron backing. This was sutured to the outer adventitia of the coronary artery using Ethicon 6-0 suture. Electromagnetic (Zepeda Instruments) or Doppler flow probes were implanted 1-3 cm distally on the same vessel. A miniature pressure gauge (Konigsberg Instruments, Inc.) was implanted in the left ventricle, and in some dogs also in the descending thoracic aorta. Heparin-filled Tygon catheters (Norton Co.) 
THE EFFECTS of nitroglycerin (NTG) and nitroprusside (NPR) on coronary vessels have been a subject of considerable interest, because these agents are used frequently in patients with ischemic heart disease and congestive heart failure. Whereas NTG'-3 and NPR"4 have been shown to decrease coronary vascular resistance in normal human subjects and experimental animals, their relative effects on large and small coronary vessels is unclear. Most information regarding the effects of these drugs on large coronary vessels is indirect. Studies in open-chest anesthetized animals, in which large coronary vessel resistance was assessed by the pressure drop from the aorta or left main coronary artery to a distal coronary arterial branch, indicate that NTG dilates large coronary vessels.74 However, in a recent study by Malindzak et al.,10 large coronary vessel resistance was assessed in the same manner, but increased substantially. Arterio- graphic studies in man also indicate that NTG"I and NPR'2 dilate large coronary vessels. Additional indirect evidence that NTG dilates large coronary vessels is derived from its salutary effect on collateral blood flow in the presence of regional myocardial ischemia. '3-'5 The beneficial effects of NPR are more controversial; it has been shqwn either to enhance"' 16 or reduce6' 16 collateral flow to ischemic myocardium.
We have developed techniques to measure coronary arterial diameter directly and continuously in conscious dogs.17 The goal of the present investigation was to use this method to compare quantitatively the effects of NTG and NPR, when equidepressor doses of the two drugs were administered systemically.
Methods
Mongrel dogs that weighed 28-38 kg were anesthetized with sodium pentobarbital, 30 mg/kg i.v. The transducers were implanted through a thoracotomy in the fifth left intercostal space. Miniature 7-MHz ultrasonic transducers (2 X 1 mm, 12 mg) were implanted on opposing surfaces of the left circumflex coronary artery 3-6 cm from its origin. The ultrasonic transducer were covered with Insl-X (Insl-X Products Corp.) and attached to a Dacron backing. This was sutured to the outer adventitia of the coronary artery using Ethicon 6-0 suture. Electromagnetic (Zepeda Instruments) The experiments were conducted with the conscious dogs' lying quietly, 1-2 weeks after operation. Measurements of left circumflex external coronary arterial diameter, aortic pressure, LV pressure, LV dP/dt, left circumflex coronary blood flow, and heart rate were continuously recorded during control, infusion of the drugs and for 1 hour after administration of the drugs. In 15 dogs, NTG and NPR were administered as i.v. infusions of 8 and 2.5 ,ug/kg/min for 7 minutes, respectively. These doses were selected to induce equidepressor effects. The equidepressor effects of these doses were confirmed. The drugs were administered at least 2 hours apart and, in some cases, on separate days. The initial drug to be examined was selected randomly. At the end of the experiments, the dogs were sacrificed to confirm placement of the ultrasonic transducers, to determine coronary arterial wall thickness, and to examine the vessel histologically. Significant fibrosis at the crystal implant site was not observed in these dogs.
The data were recorded on a 14-channel Bell and Howell tape recorder and played back on two multichannel oscillographs (Gould-Brush). Mean pressures and coronary diameters were assessed using RC filters with 2-second time constants. LV dP/dt was derived by differentiating the LV pressure signal using a Philbrick operational amplifier (Teledyne Philbrick) connected as a differentiator and having a frequency response of 700 Hz. A triangular wave signal with known slope (rate of change) was substituted for the pressure signal to calibrate the differentiator directly. The heart rate was measured continuously with a cardiotachometer triggered by the LV pressure pulse.
While external diameter was measured continuous- Mean arterial pressure fell during infusion and was 9.8 ± 1.8% below control at the end of the infusion and returned to control by 5 minutes after the infusion. LV systolic pressure followed a similar pattern. LV end-diastolic pressure decreased during the infusion by 5.6 ± 0.5 mm Hg and remained depressed for 15 minutes after the infusion. Heart rate increased during the infusion by 38 ± 6% and returned to control rapidly after infusion. LV dP/dt increased only initially by 9.7 ± 2.0% and was no longer significantly elevated at the end of the infusion. Mean coronary diameter and CSA increased, reaching peak values of 5.7 ± 0.6% and 29 ± 4.7%, respectively, at the'end of the infusion and were no longer significantly elevated 45 minutes later. Mean coronary blood flow rose by 13 ± 3.7% initially during the infusion, returned to control by the end of the infusion and fell below control by 15 ± 3.2% at 3 minutes after the infusion and returned to control 30 minutes later. LDCR demonstrated a biphasic pattern, decreasing by 16 ± 4.2% at 1 minute of infusion and remaining depressed during the infusion, but then increasing by 14 ± 3.1% above control at' 3 minutes after infusion and remaining elevated for 5 minutes after infusion.
Effects of Nitroprusside
Mean arterial pressure decreased during the infusion, was depressed by 11 ± 1.7% at the end of the infusion and was no longer different from the pre-NPR control after the infusion. LV systolic pressure 1102 CIRCULATION Heart rate increased by 46 ± 6 beats/min during the infusion and returned to control at 3 minutes after infusion. LV dP/dt increased at the beginning of the infusion by 12 ± 2.9% and then returned to control during the infusion. Mean external coronary diameter and CSA increased at the beginning of the infusion and increased by maximum values of 4.9 i 0.7% and 23 + 3.9%, respectively, at the end of infusion and were not significantly elevated 15 minutes after infusion. Mean coronary blood flow rose by 32 ± 5.6% initially, returned toward control during the infusion and fell by 18 ± 5.1% at 3 minutes after the infusion and returned back to control by 15 minutes after infusion. LDCR followed a biphasic pattern, decreasing by a maximum of 30 ± 2.5%, remained depressed throughout the infusion period, but then increased by 15 + 4 .8% at 5 minutes after the infusion, and returned to control 30 minutes after infusion.
Comparison of the Two Drugs (table 1) The two drugs elicited equivalent changes in arterial and LV systolic and end-diastolic pressures, heart rate and LV dP/dt ( fig. 2) . However, during the infusion NPR induced significantly greater increases in mean coronary flow and decreases in LDCR ( fig. 3) ease in many ways. By decreasing preload and afterload, myocardial oxygen requirements decrease, which is a potentially beneficial effect of vasodilator therapy.2'-24 However, the hypotensive action can exacerbate inadequate perfusion of ischemic coronary vessels, which are critically dependent upon perfusion pressure,`or it can elicit increases in heart rate and myocardial contractility through reflex mechanisms.26 Finally, the direct action of the drugs on coronary vascular tone must be considered. It is generally believed that agents that dilate the large, conductive coronary arteries are preferable in the presence of myocardial ischemia than those that dilate primarily resistance vessels.7'-' 13 By dilating the large conductive vessels, which include collateral channels, blood flow can be enhanced to the ischemic part of the heart. In contrast, dilating resistance vessels would be of little benefit to the ischemic area, where vessels are already nearly maximally dilated. In addition, dilation of resistance vessels in normal myocardium could be deleterious by inducing a "coronary steal." 27 The doses of NTG and NPR induced equivalent reductions in mean arterial pressure, LV systolic and end-diastolic pressures, and secondary, reflex increases in heart rate and LV dP/dt. Although both drugs elicited qualitatively similar coronary vascular effects, there were quantitative differences. NPR elicited significantly greater effects on small coronary vessels, as reflected by larger increases in mean coronary blood flow and decreases in LDCR. In contrast, NTG induced significantly greater increases in CSA. Not only were the increases larger, but they were also more sustained (fig. 4) .
The results of studies on the effects of NTG and NPR have conflicted. NTG has been shown to reduce7"9 and increase'0 large coronary vessel resistance, as assessed by calculations of pressure changes from the central aorta to a distal coronary artery. The results of the present investigation are in agreement with the studies of Fam 
